Category Filter
- Advanced Imaging
- Behavioral Health
- Chronic Condition Management
- Genetic Testing
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pre-Service Review (Precertification/Predetermination)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Hemophilia Drugs
To contribute to improved transparency around clinical management, Prime Therapeutics Hemophilia Management services will be used to perform utilization management and oversight of specialty pharmacy dispensing as part of this program.
For groups that have their pharmacy benefits carved in and participate in utilization management, Prime Therapeutics will perform the prior authorization (PA) drug reviews. The PA reviews will ensure that optimal dosing and products are being prescribed.
Use the navigation on the left or the search function above to locate specific drug policy information.
Note: Coverage is subject to the member's specific benefits. Group-specific benefits will supersede these policies when applicable. Always check eligibility and benefits through your local Blue Plan provider portal or your practice management system to confirm member-specific benefits.